ICE's $16.7 Million Shock-Glove Deal: What the Army Report Found
ICE signed a $16.7 million contract in August for 6,000 pairs of electric-shock gloves. Agency leaders had already seen an Army study that described intense pain and immediate compliance among test subjects.
The timeline comes from ICE records obtained by American Oversight and shared with the Associated Press. American Oversight published the records on Oct. 7, including the military report itself, with reporting on the documents published the same day by The Guardian.
The Army study had not been made public before. It covered a military exercise in October 2024 at the military prison at Fort Leavenworth in Kansas. Participants felt intense pain, stopped fighting right away, and feared being shocked again.
The report adds operational detail. People stopped resisting within seconds after officers applied a glove shock to skin. Afterward they were left with fatigue, soreness, and worry about being shocked again.
The device is called G.L.O.V.E., which stands for Generated Low Output Voltage Emitter. It works like a Taser worn on the hand, delivering a shock on contact. It is made by Compliant Technologies, a military-veteran-owned company based in Lexington, Kentucky.
ICE has described the gloves as distraction and de-escalation devices, meaning tools meant to interrupt resistance without lethal force, and said they will be safer than other non-lethal options. The military report itself did not evaluate safety, according to American Oversight, which said its review found the testing centered on forcing compliance through pain.
The August deal followed an earlier procurement plan. ICE had planned to spend up to $20 million to purchase thousands of "conductive distraction and de-escalation devices" for officers and agents. The signed contract set the figure at $16.7 million for 6,000 pairs.
California took a separate step. Gov. Gavin Newsom signed a law banning local, state and federal officers from using gloves that can deliver electric shocks, according to AP.
The broader context here is definitional, and definitions drive use-of-force policy. ICE describes a distraction tool with safety advantages over other non-lethal options. The Army material describes pain, rapid end to resistance, and fear of further shocks. Both descriptions can be factually accurate at once. They measure different things, one framed around tactical effect and one around subject experience.
Looking at what this means for procurement oversight, two gaps matter. The first is timing. Leaders knew the Army findings before the August signature. The second is scope. The military testing documented behavioral effects in a controlled custodial setting. It did not evaluate safety. Effectiveness is not safety.
In my view, the next questions are procedural. What safety testing, if any, did ICE rely on before signing, and will that record be disclosed? What written use policy, training requirements and reporting obligations will govern field deployment? And how will a state prohibition that by its terms includes federal officers interact with a federal contract already signed? Those answers will determine whether this remains a procurement controversy or becomes an operational and legal one, with implications for interagency cooperation, litigation risk and internal accountability.
